Brief: Repligen Corp -Consolidated Financial Statements For Quarter Ended March 31, 2023 Through June 30, For Year Ended Dec 31, 2023 Require Restatement

Repligen

18/09/2024 21:55

Repligen Corp  RGEN.O :
    * REPLIGEN CORP -CONSOLIDATED FINANCIAL STATEMENTS FOR
QUARTER
ENDED MARCH 31, 2023 THROUGH JUNE 30, FOR YEAR ENDED DEC 31,
2023  REQUIRE RESTATEMENT
    * REPLIGEN CORP -DOES NOT ANTICIPATE RESTATEMENT WILL HAVE
ANY
IMPACT ON CO’S OVERALL BUSINESS OPERATIONS, PREVIOUSLY REPORTED
STRATEGIC OUTLOOK
    * REPLIGEN: REAFFIRMING PRIOR 2024 REVENUE GUIDANCE;
UNDERSTATED
$6.6 MILLION IN H1 2024 TO BE ADDED INCREMENTALLY, THUS UPDATING
FY RANGE TO $627 MILLION-$642 MILLION

Source text for Eikon:  ID:n0001193125-24-221406 
Further company coverage:  RGEN.O